[{"address1": "12770 High Bluff Drive", "address2": "Suite 150", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858-567-7770", "website": "https://www.gyretx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. The company was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.", "fullTimeEmployees": 579, "companyOfficers": [{"maxAge": 1, "name": "Mr. Songjiang  Ma", "age": 69, "title": "President & Director", "yearBorn": 1956, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ruoyu  Chen", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 285000, "exercisedValue": 0, "unexercisedValue": 6744174}, {"maxAge": 1, "name": "Mr. Weiguo  Ye", "age": 47, "title": "Chief Operating Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 332619, "exercisedValue": 0, "unexercisedValue": 18899056}, {"maxAge": 1, "name": "Dr. Han  Ying Ph.D.", "age": 60, "title": "Senior Vice President of Science", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 397945, "exercisedValue": 0, "unexercisedValue": 3216}, {"maxAge": 1, "name": "Mr. Ping  Zhang", "age": 52, "title": "Interim CEO & Executive Chair", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 10, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.21, "open": 8.08, "dayLow": 7.97, "dayHigh": 8.25, "regularMarketPreviousClose": 8.21, "regularMarketOpen": 8.08, "regularMarketDayLow": 7.97, "regularMarketDayHigh": 8.25, "payoutRatio": 0.0, "beta": 7.077, "trailingPE": 202.25002, "forwardPE": 17.586956, "volume": 88464, "regularMarketVolume": 88464, "averageVolume": 75648, "averageVolume10days": 70970, "averageDailyVolume10Day": 70970, "bid": 5.85, "ask": 10.29, "bidSize": 2, "askSize": 2, "marketCap": 779335296, "fiftyTwoWeekLow": 6.11, "fiftyTwoWeekHigh": 13.75, "allTimeHigh": 47990.25, "allTimeLow": 2.85, "priceToSalesTrailing12Months": 7.2655134, "fiftyDayAverage": 7.649, "twoHundredDayAverage": 8.0151, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 711914176, "profitMargins": 0.06201, "floatShares": 20523048, "sharesOutstanding": 96333157, "sharesShort": 1494183, "sharesShortPriorMonth": 1384238, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0155, "heldPercentInsiders": 0.87101, "heldPercentInstitutions": 0.03483, "shortRatio": 15.77, "shortPercentOfFloat": 0.0721, "impliedSharesOutstanding": 96333157, "bookValue": 1.121, "priceToBook": 7.2167706, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": 2.212, "netIncomeToCommon": 6651000, "trailingEps": 0.04, "forwardEps": 0.46, "lastSplitFactor": "1:15", "lastSplitDate": 1698710400, "enterpriseToRevenue": 6.637, "enterpriseToEbitda": 49.58, "52WeekChange": -0.29040623, "SandP52WeekChange": 0.16255379, "lastDividendValue": 3.6, "lastDividendDate": 1673568000, "quoteType": "EQUITY", "currentPrice": 8.09, "targetHighPrice": 20.0, "targetLowPrice": 16.0, "targetMeanPrice": 18.0, "targetMedianPrice": 18.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 60049000, "totalCashPerShare": 0.661, "ebitda": 14359000, "totalDebt": 1165000, "quickRatio": 5.414, "currentRatio": 6.195, "totalRevenue": 107265000, "debtToEquity": 0.848, "revenuePerShare": 1.227, "returnOnAssets": 0.052849997, "returnOnEquity": 0.10017, "grossProfits": 102415000, "freeCashflow": 2900250, "operatingCashflow": 3877000, "earningsGrowth": 1.662, "revenueGrowth": 0.199, "grossMargins": 0.95478, "ebitdaMargins": 0.13385999, "operatingMargins": 0.22660999, "financialCurrency": "USD", "symbol": "GYRE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Gyre Therapeutics, Inc.", "longName": "Gyre Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1769807404, "regularMarketTime": 1769806800, "exchange": "NCM", "messageBoardId": "finmb_100542295", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.4616308, "regularMarketPrice": 8.09, "marketState": "CLOSED", "epsTrailingTwelveMonths": 0.04, "epsForward": 0.46, "epsCurrentYear": 0.15, "priceEpsCurrentYear": 53.93333, "fiftyDayAverageChange": 0.44099998, "fiftyDayAverageChangePercent": 0.057654593, "twoHundredDayAverageChange": 0.07490063, "twoHundredDayAverageChangePercent": 0.00934494, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1144848600000, "postMarketChangePercent": 0.0, "postMarketPrice": 8.09, "postMarketChange": 0.0, "regularMarketChange": -0.119999886, "regularMarketDayRange": "7.97 - 8.25", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 75648, "fiftyTwoWeekLowChange": 1.98, "fiftyTwoWeekLowChangePercent": 0.32405892, "fiftyTwoWeekRange": "6.11 - 13.75", "fiftyTwoWeekHighChange": -5.66, "fiftyTwoWeekHighChangePercent": -0.41163635, "fiftyTwoWeekChangePercent": -29.040623, "dividendDate": 1673481600, "earningsTimestamp": 1762522200, "earningsTimestampStart": 1762522200, "earningsTimestampEnd": 1762522200, "isEarningsDateEstimate": false, "displayName": "Gyre Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]